Traditional Chinese Medicine Genome Research and Quality Analysis
Based on chromatography, mass spectrometry and gene sequencing platform to provide services for quality identification of traditional Chinese medicine, including：DNA barcode analysis;Quality marker detection;Pesticide residue detection;Heavy metal detection.
Duxact traditional Chinese medicine detection comprehensively covers the types of drugs contained in the Pharmacopoeia of the People’s Republic of China. The company has reached a cooperative relationship with the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences (中国中医科学院中药研究所). With the support of Academician Chen Shilin, Director of the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences (中国中医科学院中药研究所), the company’s DNA barcode analysis technology has realized the scheme of rapid and accurate identification of species in large quantities, and a complete DNA barcode identification system for traditional Chinese medicines has been formed.
Duxact has made an important breakthrough in the field of genetic basis research of susceptible groups to liver injury caused by traditional Chinese medicine, and found biomarkers that can predict liver toxicity of Polygonum multiflorum Thunb. The research results were published in the top international journal of liver diseases, Hepatology (IF=14.971), and many media reported one after another.
Professor Aithal GP, director of the Digestive Disease Center of Nottingham University School of Medicine and an expert on liver diseases, said the study was "an excellent example of translational medicine research".